tiprankstipranks
Trending News
More News >
Anupam Rasayan India Ltd. (IN:ANURAS)
:ANURAS
India Market
Advertisement

Anupam Rasayan India Ltd. (ANURAS) AI Stock Analysis

Compare
0 Followers

Top Page

IN:ANURAS

Anupam Rasayan India Ltd.

(ANURAS)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - 4o)
Rating:57Neutral
Price Target:
₹1,150.00
▲(3.74% Upside)
Anupam Rasayan India Ltd. faces significant challenges in profitability and cash flow generation, which are the most impactful factors on its score. The technical indicators suggest weak market momentum, and the high P/E ratio indicates potential overvaluation. These factors collectively result in a below-average stock score.

Anupam Rasayan India Ltd. (ANURAS) vs. iShares MSCI India ETF (INDA)

Anupam Rasayan India Ltd. Business Overview & Revenue Model

Company DescriptionAnupam Rasayan India Ltd. engages in the custom synthesis and manufacturing of specialty chemicals in India. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultra violet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It also provides other specialty chemicals used in various end-user segments, comprising specialty pigments, specialty dyes, and polymer additives. It also exports its products. Anupam Rasayan India Ltd. was founded in 1984 and is based in Surat, India.
How the Company Makes MoneyAnupam Rasayan India Ltd. generates revenue through the manufacturing and sale of specialty chemicals, which are used in various industries such as agrochemicals, pharmaceuticals, personal care, and more. The company's revenue model is centered around long-term contracts and strong relationships with its clients, which include multinational corporations. Key revenue streams for Anupam Rasayan include custom synthesis and contract manufacturing services, where the company develops and produces specialty chemicals according to client specifications. Additionally, the company benefits from strategic partnerships and a focus on research and development to innovate and expand its product offerings. By maintaining stringent quality standards and leveraging its expertise in complex chemistries, Anupam Rasayan secures a competitive edge in the market, contributing to its financial growth.

Anupam Rasayan India Ltd. Financial Statement Overview

Summary
Anupam Rasayan India Ltd. displays operational efficiency and a stable balance sheet but faces challenges in profitability and cash flow generation. The company must address revenue growth inconsistencies and improve cash flow management to enhance its financial health.
Income Statement
72
Positive
The company shows a stable gross profit margin but a declining net profit margin, indicating cost pressures or increased expenses. Revenue growth is inconsistent, with a decrease in the most recent year. EBIT and EBITDA margins are healthy, reflecting solid operational efficiency despite revenue fluctuations.
Balance Sheet
65
Positive
The debt-to-equity ratio indicates moderate leverage, which is manageable but has increased over time. Return on equity is positive but has shown a declining trend, suggesting reduced profitability. The equity ratio reflects a stable financial structure, providing some cushion against liabilities.
Cash Flow
58
Neutral
The cash flow position is weak, with negative free cash flow growth and operating cash flow. The negative free cash flow to net income ratio highlights a potential issue in generating cash relative to earnings, indicating liquidity challenges.
BreakdownTTMDec 2025Dec 2023Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue14.38B14.37B16.02B14.43B10.57B8.12B
Gross Profit7.96B8.32B8.98B3.76B3.99B2.71B
EBITDA3.96B4.01B4.31B4.01B3.11B2.17B
Net Income933.48M933.49M1.81B1.29B1.52B702.96M
Balance Sheet
Total Assets52.69B52.69B37.78B46.02B28.91B22.98B
Cash, Cash Equivalents and Short-Term Investments1.35B1.35B6.67B3.48B618.77M3.15B
Total Debt13.73B13.73B8.22B10.70B8.36B4.23B
Total Liabilities21.87B21.87B12.70B16.71B11.64B7.25B
Stockholders Equity28.50B28.50B23.73B27.61B17.27B15.73B
Cash Flow
Free Cash Flow0.00-4.40B713.03M-6.57B-3.18B-1.45B
Operating Cash Flow0.00-301.25M2.92B590.32M-1.71B14.59M
Investing Cash Flow0.00-3.30B-5.23B-3.92B-4.12B-1.93B
Financing Cash Flow0.002.23B3.71B4.78B3.84B4.16B

Anupam Rasayan India Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1108.55
Price Trends
50DMA
1129.17
Negative
100DMA
1073.85
Positive
200DMA
900.10
Positive
Market Momentum
MACD
-8.04
Negative
RSI
48.51
Neutral
STOCH
56.69
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ANURAS, the sentiment is Positive. The current price of 1108.55 is below the 20-day moving average (MA) of 1110.90, below the 50-day MA of 1129.17, and above the 200-day MA of 900.10, indicating a neutral trend. The MACD of -8.04 indicates Negative momentum. The RSI at 48.51 is Neutral, neither overbought nor oversold. The STOCH value of 56.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:ANURAS.

Anupam Rasayan India Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
108.15B26.7913.41%0.52%8.49%20.80%
66
Neutral
107.09B57.3713.27%0.48%10.29%26.09%
62
Neutral
93.25B42.8616.95%0.20%21.50%78.82%
61
Neutral
80.11B33.6818.65%0.19%17.58%14.66%
59
Neutral
114.28B40.788.58%0.70%2.60%60.61%
57
Neutral
₹126.21B98.69
0.07%24.37%29.82%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:ANURAS
Anupam Rasayan India Ltd.
1,086.75
337.14
44.98%
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
2,074.20
-290.84
-12.30%
IN:GARFIBRES
Garware Technical Fibres Limited
807.05
10.11
1.27%
IN:JUBLINGREA
Jubilant Ingrevia Ltd.
709.15
-40.79
-5.44%
IN:PRIVISCL
Privi Speciality Chemicals Limited
2,448.70
988.71
67.72%
IN:TIMETECHNO
Time Technoplast Limited
476.10
63.87
15.49%

Anupam Rasayan India Ltd. Corporate Events

Anupam Rasayan Appoints New Secretarial Auditor for Enhanced Compliance
Sep 1, 2025

Anupam Rasayan India Ltd. has announced the appointment of M/s. M.D. Baid & Associates as the Secretarial Auditor for a five-year term starting from the financial year 2025-26. This strategic move is subject to approval at the upcoming Annual General Meeting and is expected to enhance the company’s compliance and governance framework, potentially strengthening its market position and stakeholder confidence.

Anupam Rasayan India Ltd. Re-appoints Key Directors for Continued Leadership
Sep 1, 2025

Anupam Rasayan India Ltd. announced the re-appointment of Mr. Anand Sureshbhai Desai as Managing Director and Mrs. Mona Anandbhai Desai as Whole-time Director, each for a five-year term starting April 2026. This decision underscores the company’s commitment to stable leadership and continuity, potentially reinforcing its strategic direction and operational consistency, which could positively impact stakeholders and the company’s industry standing.

Anupam Rasayan Re-appoints Key Directors to Strengthen Leadership
Sep 1, 2025

Anupam Rasayan India Ltd. announced the re-appointment of Mr. Anand Sureshbhai Desai as Managing Director and Mrs. Mona Anandbhai Desai as Whole-time Director for another five-year term starting April 2026. These re-appointments reflect the company’s commitment to maintaining its leadership and strategic direction under experienced management, which is expected to positively impact its operations and stakeholder confidence.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 19, 2025